Professor Hung, Fan Ngai Ivan 孔繁毅
Professor Ivan Fan Ngai HUNG is currently Ru Chien and Helen Lieh Endowed Professor in Health Sciences Pedagogy, Clinical Professor and Assistant Dean (Admissions), Chief of the Division of Infectious Diseases, Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, and Honorary Consultant in Queen Mary Hospital, Hong Kong. He is also Clinical Professor and Chief-of-Service of the Department of Infectious Diseases and Clinical Microbiology at the HKU-Shenzhen Hospital.
Professor Hung is a dual specialist in Infectious Disease and Gastroenterology & Hepatology. He obtained his medical degree from the University of Bristol Medical School, England in 1996. After working in the University of Cambridge Medical School and Charing Cross Hospital, London, he returned to Hong Kong in 1999 and joined the Department of Medicine, Queen Mary Hospital. He was awarded the Anti-SARS gold badge award by the Hospital Authority in 2003 for his role in combating SARS as frontline medical officer. He received the Sir Patrick Manson Gold Medal award for best M.D. thesis. He was awarded the Richard Yu Lectureship and medal in 2016 by the Hong Kong College of Physicians. He was awarded the prestigious Outstanding Researcher Award from the University of Hong Kong in 2019. He is currently the Fellow of Royal Colleges of Physicians of London and Edinburgh.
Professor Hung has published more than 220 international peer reviewed original articles, including research articles in the Lancet, the Lancet Infectious Diseases and the Clinical Infectious Diseases. His research interest includes influenza, SARS-CoV-2 and other respiratory virus antiviral treatment and vaccinology. He and his team have pioneered the use of the triple combination of interferon beta-1b, lopinavir/ ritonavir and ribavirin in the treatment of hospitalized COVID-19 patients, resulting in significantly faster clinical alleviation and viral load suppression. He and his team also pioneered the application of topical imiquimod before intradermal influenza vaccination, which results in protection against heterologous non-vaccine and antigenically drifted viruses. His team was also the first to prove convalescent plasma and H-IVIG reduced mortality in patients with severe influenza infection in prospective clinical trials. He is ranked as HKU Scholars in the world top 1% in 2013, 2018-2020.
As a clinician scientist, Professor Hung believes in innovation, team-work and clinical application of translational research in tackling threats from emerging infectious diseases.
|Awardees||Award Date||Honours / Awards / Prizes||Category|
|2020-02-01||Outstanding Researcher Award 2018-19: The University of Hong Kong||Research Achievement|
|2017-12-01||Distinguished Young Fellow 2017: Hong Kong College of Physicians, Hong Kong Academy of Medicine||Others|
|2016-10-01||The Richard Yu Lectureship Award for Distinguished Physician - Investigators below the age of 45 years 2016: Hong Kong College of Physicians||Research Achievement|
|2006-01-01||Best poster presentation award "Fatal Interaction Between Clarithromycin And Colchicine In Patients With Renal Insufficiency: A Retrospective Study": 11th MRC Meeting 2006||Research Achievement|
|2011-10-01||Best Oral Presentation Award “Five Days Quadruple Versus Clarithromycin Containing Triple Therapy As Empirical First And Second-line Treatment For Helicobacter Pylori Eradication: A Randomized Crossover Trial”: 19th European Gastroenterology Week (UEGW) Stockholm, Sweden 2011.||Research Achievement|
|2004-03-01||Best free paper oral presentation: 9th Annual Scientific Meeting HKID Society||Research Achievement|
|2011-10-01||Distinguished Research Paper Award For Young Investigators 2011 : “Prevention Of Acute Myocardial Infarction And Stroke In The Elderly By Pneumococcal And Influenza Dual Vaccinations: A Prospective Cohort Study.”: Hong Kong College Of Physicians||Research Achievement|
|2003-09-01||Anti-SARS Gold Badge Award (Hospital Authority, Hong Kong): Hospital Authority||Research Achievement|
|2012-10-01||Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain: Best Abstract in Clinical Medicine (Oral), 18th Medical Research Conference, Department of Medicine, HKU; 2013||Research Achievement|
|2012-01-01||Sir Patrick Manson Gold Medal – Best M.d. Thesis: Innovations In The Treatment And Prevention Of Influenza: Faculty Of Medicine, The University Of Hong Kong||Research Achievement|
|2015-01-01||Best Abstract in Clinical Medicine (Oral) - "Immunogenicity of Intradermal Trivalent Influenza Vaccine with Topical Imiquimod, a Double Blind Randomized Controlled Trial": 20th Medical Research Conference 2015, Department of Medicine, The University of Hong Kong||Research Achievement|
|2014-01-01||Best Abstract in Clinical Medicine (Oral) - "Hyperimmune Intravenous Immunoglobulin Treatment: A Multicenter Double Blind Randomized Controlled Trial for Patients with Severe A (H1N1) pdm 09 Infection": 19th Medical Research Conference 2014, Department of Medicine, The University of Hong Kong,||Research Achievement|
|2016-02-01||Research Output Prize 2015-16: Faculty of Medicine, The University of Hong Kong, The Lancet Infectious Diseases||Research Achievement|
|Term Period||Position||Professional Societies|
|03/2008 - now||Member||Hong Kong Association for the Study of Liver Diseases|
|03/2004 - now||Member||Hong Kong Society of Infectious Disease|
|03/2009 - now||Member||Hong Kong Society of Gastroenterology|
|Member||Hong Kong Medical Association|
Are You Missing Publications, Invited Lectures? Click Me.